Precision cell-state silencing of injured afferents alleviates spontaneous neuropathic pain
By developing an injury-responsive viral vector that achieves over 95% specificity for injured sensory neurons, researchers successfully used chemo- and optogenetic silencing to alleviate spontaneous neuropathic pain in mice without compromising normal sensory function, establishing precision cell-state targeting as a promising therapeutic strategy for chronic pain.